我的购物车

Human iPSC-Derived Cardiac Organoid Differentiation Kit

用户评价
货号-规格
价格
Qty.
合计0件 产品金额0
0
加入购物车

产品详情

  • 组分(Materials Provided)

    Box A(2-8°C)
    ID
    Components
    Size
    RIPO-HWM002K-C01
    Basal medium A
    5.4ml
    RIPO-HWM002K-C02
    Basal medium B
    22.5ml
    RIPO-HWM002K-C03
    Basal medium C
    27ml
    RIPO-HWM002K-C04
    Basal medium M-M
    22.5ml
    Box B(-20°C)
    ID
    Components
    Size
    RIPO-HWM002K-1-C01
    Medium F
    3ml
    RIPO-HWM002K-1-C02
    Supplement A
    0.6ml
    RIPO-HWM002K-1-C03
    Supplement B
    2.5ml
    RIPO-HWM002K-1-C04
    Supplement C
    3ml
    RIPO-HWM002K-1-C05
    Supplement M-M
    2.5ml
  • 产品描述(Product Details)

    Human iPSC-Derived Cardiac Organoid differentiation Kit (Catalog No#: RIPO-HWM002K) allows hESC or iPSC to differentiate into cardiac organoids. Cardiac organoids are three-dimensional in vitro models with a cellular composition and structural organization that is representative of the human heart. This kit can produce 24 cardiac organoids in four steps. Differentiation was carried out by forming EBs from PSC at an ultra-low adsorption interface, and then changing the medium according to the instructions. A spontaneously beating cardiac organoid with a cavity can be seen between days 9 and 13 of the onset of differentiation. Cardiomyocyte, key cellular component of cardiac organoid, are responsible for the beating of the cardiac organoids. The beating rate of the formed cardiac organoids increases dramatically when stimulated with isoproterenol or forskolin, and there is a linear relationship between the concentration of the drug and the beating rate over a range of concentrations.

  • 产品特征(Product Specification)

    The basic medium of this differentiation kit is a serum-free, well-defined medium with minimal batch variation to which differentiation factors are added. This medium does not contain antibiotics, the addition of which may affect cardiac organoid differentiation.

  • 存储(Storage)

    The unopened Box A is stable for 12 months from the date of manufacture if stored under 2-8°C.
    The unopened Box B is stable for 12 months from the date of manufacture if stored under -20°C.
    The opened kit should be stored according to components table.

  • *请注意,为了支持完整的类器官培养和维持过程,本产品必须与Human iPSC-Derived Cardiac Organoid Maintenance Kit (Cat. No. RIPO-HWM004)一起使用。您可以点击此链接获取产品信息。
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

产品展示

  • 产品示意(Product Diagram)

     Organoids PRODUCT DIAGRAM

    Protocol Diagram of cardiac organoid differentiation.

验证
  • Organoid Histology and State

     Organoids ORGANOID HISTOLOGY AND STATE

    The cardiac organoids differentiated using the Human iPSC-Derived Cardiac Organoid Differentiation Kit (Ca. No. RIPO-HWM002K) show regular beating from day 7-13 of differentiation.

  • Marker Expression

     Organoids MARKER EXPRESSION

    The cardiac organoids differentiated using the Human iPSC-Derived Cardiac Organoid Differentiation Kit (Ca. No. RIPO-HWM002K) demonstrate the expression of cardiomyocyte marker cTnT (green) and vascular endothelial cell CD31(red)

  • Organoid Activity

     Organoids ORGANOID ACTIVITY

    The electrical activity of the cardiac organoids differentiated using the Human iPSC-Derived Cardiac Organoid Differentiation Kit (Ca. No. RIPO-HWM002K) was recorded using silicon probes (Ca. No. P64-7), revealing electrophysiological activity that closely resembles that of the actual human heart.

     Organoids ORGANOID ACTIVITY

    The cardiac organoids differentiated using the Human iPSC-Derived Cardiac Organoid Differentiation Kit (Ca. No. RIPO-HWM002K) show stable electrical activity

  • Organoid Application

     Organoids ORGANOID APPLICATION

    E4031 caused the prolongation of QT interval on cardiac organoid measuring by MEA

     Organoids ORGANOID APPLICATION

    Drug A cause damage to both cardiomyocytes and epithelial cells (Vascular) on Cardiac organoid.

用户评价
发表评论

前沿进展

 
联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品详情
  • 产品展示
  • 用户评价